Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related ALR
Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere
Goldman Sachs Upgrades Alere To Neutral
Related SCHW
Analyst: TD Ameritrade, Charles Schwab Could Benefit From This Secular Shift
Barclays Upgrades Charles Schwab As The Fed Continues Its Trend To Normalization
Schwab Cuts Senior Officer Pay, CEO's Salary Down 7% - Analyst Blog (Zacks)

Analysts at Wedbush downgraded Alere (NYSE: ALR) from “outperform” to “neutral.” The target price for Alere is set to $21.50. Alere's shares closed at $22.66 on Friday.

Analysts at Citigroup downgraded Charles Schwab (NYSE: SCHW) from “neutral” to “sell.” The target price for Charles Schwab has been lowered from $15 to $14. Charles Schwab's shares closed at $16.89 on Friday.

Analysts at Benchmark downgraded Fossil (NASDAQ: FOSL) from “buy” to “hold.” The target price for Fossil is set to $105. Fossil's shares closed at $103.90 on Friday.

UBS downgraded Sigma-Aldrich (NASDAQ: SIAL) from “neutral” to “sell.” The target price for Sigma-Aldrich has been lowered from $76 to $70. Sigma-Aldrich's shares closed at $77.66 on Friday.

Latest Ratings for ALR

DateFirmActionFromTo
Mar 2015Goldman SachsUpgradesSellNeutral
Mar 2015JefferiesMaintainsBuy
Feb 2015JefferiesMaintainsBuy

View More Analyst Ratings for ALR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (FOSL + ALR)

Around the Web, We're Loving...